Explore more Johnson & Johnson sites:
Jump to:
Suppliers
Suppliers
Our Suppliers Help Us Fulfill Our Mission
Our Suppliers Help Us Fulfill Our Mission
At Johnson & Johnson we are helping transform healthcare with innovative supplier solutions.
ust as we believe that good health is the foundation of vibrant lives, thriving communities and forward progress, at Johnson & Johnson we also pride ourselves on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability.
With an extended supply base comprising about 50,000 suppliers across our three business segments, we proudly honor our commitment to inclusion by building a global group of suppliers that reflects the diversity of our patients and customers.
Working with our valued partners, we uphold the highest standards for responsible sourcing and corporate citizenship, encouraging our suppliers to embrace new technologies, source innovative solutions and deliver new business models that contribute to our mutual objectives for growth, sustainability and streamlined processes.
As we advance our vision of a healthier world for all, we will continue to use our reach and size for good as we pioneer this differentiated, industry-leading procurement approach—one that is innovative, collaborative, ethical, sustainable, diverse and, above all, rooted firmly in Our Credo.
We have always considered our suppliers to be an extension of our supply chain and our workforce. Nothing we do would be possible without the hard work and commitment of each and every one of them.
Amid the pandemic and widespread supply chain disruptions, the company achieved $5.2 billion in global impact spending with diverse and small suppliers in 2021, exceeding our Health for Humanity 2025 goal in just one year.
In China, when the need for a highly advanced, nonsurgical treatment for atrial fibrillation (AFib) exceeded the supply of doctors trained in the lifesaving procedure, Johnson & Johnson's Procurement team asked for a chance to help.
More from Johnson & Johnson
-
Over the past few decades, advances in the study and treatment of this inflammatory bowel disease have rapidly accelerated. We spoke to the experts to learn the latest about managing Crohn's disease—and what other potential breakthroughs are on the horizon.
-
Johnson & Johnson's Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That's where he met Tiko Kerr, who became one of the first patients to take the company's HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
-
What do diseases like multiple myeloma and lupus have in common? They're more prevalent in people of color—yet historically these patients have been left out of clinical research, often to dire health consequences. Learn how Johnson & Johnson is working to make the study of conditions like these more equitable.
